Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy

In up to 72 % of HER2+ invasive breast cancer (IBC), a ductal carcinoma in situ (DCIS) component is present. The presence of DCIS is associated with increased positive surgical margins after breast-conserving surgery (BCS). The aim of this study was to assess surgical margins, recurrence and surviva...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of surgical oncology 2024-09, Vol.50 (9), p.108465, Article 108465
Hauptverfasser:	Ploumen, Roxanne A.W., Claassens, Eva L., Kooreman, Loes F.S., Keymeulen, Kristien B.M.I., van Kats, Maartje A.C.E., van Kuijk, Sander M.J., Siesling, Sabine, van Nijnatten, Thiemo J.A., Smidt, Marjolein L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Ductal carcinoma in situ Invasive breast cancer Neoadjuvant systemic therapy Prognosis Surgical margins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!